SCHEMBL19477707

SCHEMBL19477707

C=C(C)[C@]1(N)CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 15/20 0.54
CNR1 P21554 11/20 0.54
OPRM1 P35372 8/20 0.54
TRPV1 Q8NER1 4/20 0.54
TRPM8 Q7Z2W7 4/20 0.54
GPR55 Q9Y2T6 4/20 0.54
CYP1A1 P04798 2/20 0.54
CYP2D6 P10635 2/20 0.54
CYP2B6 P20813 2/20 0.54
SLC6A2 P23975 2/20 0.54
CYP2C19 P33261 2/20 0.54
SLC6A3 Q01959 2/20 0.54
TRPA1 O75762 2/20 0.54
TRPV3 Q8NET8 2/20 0.54
TRPV4 Q9HBA0 2/20 0.54
TRPV2 Q9Y5S1 2/20 0.54
GPR6 P46095 1/20 0.54
NAAA Q02083 1/20 0.54
DAGLA Q9Y4D2 1/20 0.54
HTR1A P08908 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22847424 0.92 CNR2 (0.56) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL21344323 0.90 CNR2 (0.47) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL23975514 0.84 CNR2 (0.55) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24703760 0.84 CNR2 (0.55) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24703758 0.84 CNR2 (0.55) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL21368253 0.82 CNR2 (0.38) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24703849 0.78 CNR2 (0.57) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24703848 0.78 CNR2 (0.57) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL22480448 0.77 CNR2 (0.43) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL23052897 0.77 CNR2 (0.57) CNR2CNR1OPRM1TRPV1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230284578-A1 EXTRACTS OF CBD AND THC NEXUS AGRISCIENCE, INC. 2023-09-14 US disclosed
WO-2017178807-A1 USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA GW Research Limited (GB) 2017-10-19 WO disclosed